IL57790A - Isoureido(isothioureido)alkylamino pyrimidone derivatives,process for their preparation and pharmaceutical compositions containing them - Google Patents

Isoureido(isothioureido)alkylamino pyrimidone derivatives,process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL57790A
IL57790A IL57790A IL5779079A IL57790A IL 57790 A IL57790 A IL 57790A IL 57790 A IL57790 A IL 57790A IL 5779079 A IL5779079 A IL 5779079A IL 57790 A IL57790 A IL 57790A
Authority
IL
Israel
Prior art keywords
isoureido
isothioureido
alkylamino
preparation
pharmaceutical compositions
Prior art date
Application number
IL57790A
Other languages
English (en)
Other versions
IL57790A0 (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of IL57790A0 publication Critical patent/IL57790A0/xx
Publication of IL57790A publication Critical patent/IL57790A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL57790A 1978-07-15 1979-07-13 Isoureido(isothioureido)alkylamino pyrimidone derivatives,process for their preparation and pharmaceutical compositions containing them IL57790A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7829999 1978-07-15

Publications (2)

Publication Number Publication Date
IL57790A0 IL57790A0 (en) 1979-11-30
IL57790A true IL57790A (en) 1984-01-31

Family

ID=10498456

Family Applications (1)

Application Number Title Priority Date Filing Date
IL57790A IL57790A (en) 1978-07-15 1979-07-13 Isoureido(isothioureido)alkylamino pyrimidone derivatives,process for their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (4) US4305945A (de)
EP (1) EP0007232A1 (de)
JP (1) JPS5515499A (de)
KR (1) KR830001247A (de)
AR (1) AR226420A1 (de)
AT (1) AT370728B (de)
AU (1) AU528878B2 (de)
CA (1) CA1114375A (de)
DD (1) DD144916A5 (de)
DK (1) DK293079A (de)
ES (1) ES482448A1 (de)
FI (1) FI792220A (de)
GR (1) GR69252B (de)
IL (1) IL57790A (de)
NO (1) NO792337L (de)
NZ (1) NZ191006A (de)
PH (1) PH15979A (de)
PL (1) PL217121A1 (de)
PT (1) PT69886A (de)
ZA (1) ZA793392B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (de) * 1978-02-13 1983-03-05 Smith Kline French Lab
IL57005A (en) * 1978-04-11 1983-11-30 Smith Kline French Lab Process for the preparation of 2-amino pyrimid-4-one derivatives and novel 2-nitroaminopyrimid-4-ones as intermediates therefor
PT69886A (en) * 1978-07-15 1979-08-01 Smith Kline French Lab Process for preparing isoureas and isothioureas
DK558181A (da) * 1981-01-30 1982-07-31 Smithkline Corp Fremgangsmaade til fremstilling af 3,5-diamino-1,2,4-triazoler
US4477663A (en) * 1981-02-06 1984-10-16 Smithkline Beckman Corporation Intermediates for preparing substituted pyrimidinones
US4620001A (en) * 1981-02-06 1986-10-28 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
DE3532880A1 (de) * 1985-09-14 1987-03-26 Basf Ag 1,4-disubstituierte pyrazolderivate
EP4196793A1 (de) 2020-08-11 2023-06-21 Université de Strasbourg Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1223686A (en) 1967-02-24 1971-03-03 Ici Ltd Salts of pyrimidine derivatives and the use thereof as fungicides
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
US4218452A (en) * 1975-10-02 1980-08-19 Smith Kline & French Laboratories Limited Substituted 4-pyrimidone compounds, compositions and methods of use
GB1578219A (en) * 1975-12-01 1980-11-05 Smith Kline French Lab Isothioureas
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
IN151188B (de) * 1978-02-13 1983-03-05 Smith Kline French Lab
PT69886A (en) * 1978-07-15 1979-08-01 Smith Kline French Lab Process for preparing isoureas and isothioureas

Also Published As

Publication number Publication date
JPS5515499A (en) 1980-02-02
US4439435A (en) 1984-03-27
IL57790A0 (en) 1979-11-30
GR69252B (de) 1982-05-11
NZ191006A (en) 1982-09-07
NO792337L (no) 1980-01-16
PH15979A (en) 1983-05-16
ATA492279A (de) 1982-09-15
DK293079A (da) 1980-01-16
AR226420A1 (es) 1982-07-15
PL217121A1 (de) 1980-06-16
FI792220A (fi) 1980-01-16
US4558128A (en) 1985-12-10
US4639519A (en) 1987-01-27
AU4895479A (en) 1980-01-24
US4305945A (en) 1981-12-15
CA1114375A (en) 1981-12-15
AT370728B (de) 1983-04-25
KR830001247A (ko) 1983-04-29
PT69886A (en) 1979-08-01
AU528878B2 (en) 1983-05-19
DD144916A5 (de) 1980-11-12
EP0007232A1 (de) 1980-01-23
ES482448A1 (es) 1980-04-01
ZA793392B (en) 1980-08-27

Similar Documents

Publication Publication Date Title
IL56734A0 (en) Phemoxyalkylcarboxylic acid derivatives,process for their preparation and pharmaceutical compositions containing thesame
DE2860900D1 (en) Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
MY8500590A (en) Pyrimidones, process for their preparation and pharmaceutical compositions containing them
IL63913A0 (en) Pyrimidone derivatives,process for their preparation,pharmaceutical compositions containing them and their use
DE2960954D1 (en) 1-aryloxy-3-nitratoalkylamino-2-propanols, process for their preparation and pharmaceutical compositions
IL57901A0 (en) Indanyl derivatives,process for their preparation and pharmaceutical preparations containing them
DE3062310D1 (en) Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them
DE2963573D1 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
DE2861361D1 (en) 1-n-acylated-4-o-glycosyl-6-o-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them
DE2964209D1 (en) Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them
DE2966413D1 (en) Pyrimidinone derivatives, processes for preparing them and pharmaceutical compositions containing them
IL57790A0 (en) Isoureido(isothioureido)alkylamino pyrimidone derivatives,process for their preparation and pharmaceutical compositions containing them
DE2962112D1 (en) Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
IL57599A0 (en) Indolealkylamines,pharmaceutical formulations containing these and processes for their preparation
DE3165733D1 (en) Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them
ZA793682B (en) New piperidylbenzimidazolinone derivatives,processes for their preparation and pharmaceutical compositions containing them
IL57533A (en) 17alpha-acetylene derivatives of androst-4-ene,process for preparing them and pharmaceutical compositions containing them
DE2861767D1 (en) Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them
DE2960503D1 (en) Novel androstadienes, processes for their preparation and pharmaceutical compositions containing them
DE2961213D1 (en) Thieno and furopyridone derivatives, process for their preparation and medicinal preparations containing them
DE2966639D1 (en) Benzodiazepine derivatives, process for their preparation and pharmaceutical compositions containing them
DE2962542D1 (en) Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them
DE2962303D1 (en) Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them
IL54336A (en) Pyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them
DE2961627D1 (en) Azathianaphthalene derivatives, process for their preparation, pharmaceutical preparations containing them and their utilisation